−17.1120USD
−35.81 MUSD
4.35 M
About eFFECTOR Therapeutics, Inc.
Sector
Industry
CEO
Stephen T. Worland
Website
Headquarters
Solana Beach
Employees (FY)
14
Founded
2012
FIGI
BBG00YMYC7F1
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in Solana Beach, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
